Researchers from Tokyo Metropolitan University have uncovered new insights into how the proteins GRB2 and SOS1 in cells pass signals from membrane receptors to nuclei.
CDER tweaks Ozempic’s post-marketing label to include risk for GI disorder
CDER has added two post-marketing caveats to the label of Novo Nordisk’s blockbuster diabetes drug Ozempic, including a warning for a condition related to a